Paramount Pharmaceuticals Information

Paramount Pharmaceuticals manufactures prescription medicines at its plant on the Industrial Triangle, Kahuta Road, Islamabad. Manufacturing began here in 1994. The company produces 266 registered formulations across twelve therapeutic segments, including antibiotics, cardiovascular, central nervous system, gastrointestinal, respiratory and dermatological medicines, in tablet, capsule, dry suspension, oral liquid, cream, ointment and gel form. MANUFACTURING Five production sections operate under a single DRAP GMP certificate. Cephalosporins are made in a physically segregated section with separate air handling and material flows. Every batch is tested and released against a Certificate of Analysis. QUALITY SYSTEMS Paramount's management systems are certified to ISO 9001, ISO 14001 and ISO 45001 by TUV AUSTRIA CERT, covering the manufacture of oral and topical pharmaceutical products. INTERNATIONAL BUSINESS Paramount supplies ten export markets across Asia and Africa. Private-label and buyer-brand programmes are available across the range, with registration support and market-specific artwork for importing partners. PARAMOUNT HEALTHCARE Paramount HealthCare is the company's nutraceutical and consumer healthcare business, operating a dedicated unit since 2016. Paramount Pharmaceuticals is a subsidiary of Paramount Inc., Tokyo, established in Japan in 1982. For international business, distribution and private-label enquiries: export@paramount.net.pk